Browse Category

Neuroscience News 17 August 2025 - 17 November 2025

Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

On November 17, 2025, Annovis Bio, Inc. (NYSE: ANVS) released new Phase 3 data in early Parkinson’s disease showing that its lead drug candidate buntanetap halted cognitive decline and improved key Alzheimer’s-related biomarkers in a significant subset of patients. Annovis
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

A One‑Time Brain Gene Therapy Just Slowed Huntington’s by 75%—Is This the Turning Point Families Have Waited For?

Key facts (quick read) In‑depth report 1) Huntington’s disease, in plain English What it is. HD is a progressive brain disorder that typically begins in mid‑adulthood, causing a mix of movement (chorea, dystonia), cognitive (processing speed, executive function) and psychiatric symptoms
Star ‘Stripped to the Bone’, Antarctic Sea Ice Alarm, and Brain Aging Reversed – Science News Roundup (Aug 20–21, 2025)

Star ‘Stripped to the Bone’, Antarctic Sea Ice Alarm, and Brain Aging Reversed – Science News Roundup (Aug 20–21, 2025)

Space & Astronomy Climate & Environment Health & Medicine Biology & Ecology Physics & Chemistry Technology & AI Sources: The information above is drawn from peer-reviewed studies, official press releases, and reputable science media reports published on August 20–21, 2025.
Go toTop